Registration Dossier

Diss Factsheets

Administrative data

Description of key information

The genotoxicity of the substance has been assessed based on in vitro information for three genotoxicity endpoints: genotoxicity in bacteria (with Dihydromyrcenyl acetate, supported with Dihydromyrcenol), cytogenicity in a micronucleus test (with Dihydromyrcenyl acetate) and genemutation test in mammalian cells using read across from Dihydromyrcenol, resulting in the absence of genotoxicity.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Justification for classification or non-classification

The genotoxicity of the substance has been assessed based on in vitro information for three genotoxicity endpoints: genotoxicity in bacteria (with Dihydromyrcenyl acetate, supported with Dihydromyrcenol), cytogenicity in a micronucleus test (with Dihydromyrcenyl acetate) and genemutation test in mammalian cells using read across from Dihydromyrcenol, resulting in the absence of genotoxicity.

Therefore no genotoxic carcinogenicity is expected, via the oral, inhalation and dermal route. The substance does not have to be classified for genotoxic carcinogenicity via the oral, inhalation and dermal route in accordance with the criteria outlined in EU CLP (EC No. 1272/2008 and its updates).

Additional information